EGFR and glioblastoma: To control for off target effects of DOX, we treated EGFR GBM primary cell cultures (Zhu et al, 2009; Acquaviva et al, 2011; Jun et al, 2012) with DOX (10 μg/ml) for 48 h and showed no significant impact on the cell viability (Fig 7D–F).